Cynosure Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8,260	Closed	-$494K	–	167
2018 Q2	$494K	Buy	8,260 +2,930	+55%	+$175K	0.13%	105
2018 Q1	$244K	Buy	5,330 +60	+1%	+$2.75K	0.06%	200
2017 Q4	$210K	Buy	+5,270	New	+$210K	0.05%	219